for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Oncolytics Biotech Inc reports qtrly share of $0.02

Nov 8 (Reuters) - Oncolytics Biotech Inc:

* Oncolytics Biotech Inc. announces 2017 third quarter results

* At September 30, 2017, company reported $14.0 million in cash and cash equivalents; cash runway expected to end of 2018

* Oncolytics Biotech Inc qtrly basic and diluted loss per common share $0.02 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up